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1AIMS OF THE STUDY
1. To assess the value of serum C reactive protein levels as the
biochemical severity marker as compared against Computed
Tomography Severity Index(CTSI) as standard in acute pancreatitis to
differentiate mild from severe acute pancreatitis.
2. To find the correlation of significantly raised levels of serum CRP
with local changes in pancreas, mainly pancreatic necrosis.
3. To find the relationship between C reactive protein levels and CTSI
with number of days of admission in the local hospital and thereby
morbidity of disease.
ORIGINAL ARTICLES:
Gnnuy gurleyik et al. article titled computed tomography
severity index APACHE II score and serum CRP concentrations for
predicting the severity of acute pancreatitis. Jop. J pancreatitis (online
2005) , department of surgery, department of surgery and department of
radiology  hay darpara numme education and research hospital, Istanbul
turkey concluded that CTSI is a better marker  and correlates with the
clinical course , severity o f disease and has better accuracy rates when
compared with APACHE II and CRP level. And levels of CRP and
2APACHE  II  does  not  give  the  extent  of  local  inflammation.  And
complication which is given by CTSI.
2.  AD  et  al  Meyer, article titled C reactive protein an aid to
assessment and monitoring of acute pancreatitis j clinical pathol 1984,
university, Department  of surgery General infirmary Leeds and the unit
for cancer research , university of Leeds, compared CRP with alpha 1
anti chymotrypsin and alpha 1 protease inhibitor using WBC count and
ESR as reference data, conclude that CRP differentiates mild and severe
attacks with greatest precision.and serial elevated values of CRP at the
end of 1 week of admission can differentiate patients who develop local
complication and collection.
3.  Raffaele Pezzilli et al, article titled assessment of severity of
acute pancreatitis a comparison between old and recent modalities used
to evaluate perennial problem. World journal of gastroenterology1999,
august compared clinical biochemical and radiological criteria. For
assessing severity and concluded that at present CRP is the marker
which is earliest to perform and which has lowest cost among all
markers.
4. Chun Chia Chen et all. Article titled serum markers in the early
assessment of acute pancreatitis which is most useful. Jichin med assoc
32004:67:439-441 Division of gastroenterology, Department of medicine.
Taipei veterans general hospital and national Yang ming university
school of medicine, Taiwan. Concluded that serum interleukin 6 levels
on the first day and CRP on the second day are useful for early
prediction of severity of acute pancreatitis.
5. Ahmed z et al, article titled clinical laboratory assessment of
acute pancreatitis. Clinica chimica acta (2005) 26-48, department of
surgery Manchester royal infirmary. Manchester concluded that CRP is
both a marker of severity and pancreatic necrosis in acute pancreatitis.
6. M.T. Hamalainen et al., article titled do normal leukocyte and
CRP on admission exclude a life threatening attack of acute pancreatitis.
Scandinavian  journal of surgery 91-352-356, Department  of surgery
university of Turkey, Finland concluded that it is very unlikely that AP
episode is life threatening with normal WBC and CRP values at
admission.
4REVIEW OF LITERATURE
History
Ambrose pare, a French surgeon is the first to describe
pancreatitis. In the 17th and  early  18th century Johann Wirsung and
Santorini described Main Pancreatic Duct and Accessory Pancreatic
Duct respectively.
In 1862, la Dentu was the first surgeon to operate on
pancreatitis.In 19th century clinical description of pancreatitis was given
by Huber Fitz who differentiated suppurative, haemorrhagic and
gangrenous form of disease.
In 1925, George Andrew Moynihan explained pancreatitis as a
important inflammatory disorder of pancreas. Closely followed by
Elman.R in 1929, giving the associate of serum amylase with
pancreatitis.
First prognostic index , the Ransons scoring system was given by
John HL Ranson in 1974 which goes by his name. The basis for our
understanding of pancreatitis and its management both surgical and
conservative was given by him.
51978-glascow scoring system Clement .W.Imrie
1981-APACHE William A Knaws
          Inaccurate and so lead to better system
          APACHE II
1989- Balthazar after the invent of CT, its usefulness in
diagnosis and assessing severity of pancreatitis.
1992- Atlanta classification system- definition for different
terminologies
Surgical anatomy:
It is the retroperitoneal organ situated behind lesser omentum and
stomach. Its extension is from c-loop of duodenum to splenic hilum.The
gland is yellow tan coloured and it is multi lobulated.
Posterior relation- IVC, right renal vein, SMC vessels, aorta at
L1 and splenic vein.
Divided into head, neck, body and tail.Head is situated in c loop
of duodenum.Neck lies over SMC vessels and portal vein. Part of head
6passing behind the SM vein to the left is Uncinate process. Tail extends
upto hilum of spleen.
Blood supply:
Arterial:
Head and neck-arcades from hepatic and gastroduodenal of celiac
and branch from first part of SMA.
Body and tail- arcade from splenic artery.
Vein- along SMC, splenic and portal vein.
Lymphnode areas:
Head: portal, sub pyloric, mesenteric, mesocolic and aorto caval
nodes. Body and tail: aortocaval, celiac, mesenteric, mesocolic and
splenic hilum nodes.
Nerve supply:
Both sympathetic and parasympathetic innervation . Sympathetic
nerves carry pain sensation and are targets during sphlancnectomy done
for pain relief in chronic pancreatitis.
7Pre ganglionic fibres arise from sympathetic ganglia in thorax
relays at celiac ganglia from where post ganglionic fibres arise and
supply the gland.
Microanatomy:
It is organised into units termed acini and islets of Langerhans
which are exocrine and endocrine respectively.
Acinar cells- Polarised synthetic secretory cells with golgi and
zymogen granules at its apex-secretes about 1 litre of pancreatic fluid
per day rich in enzymes and bicarbonate.
Islets of Langerhans has rich blood supply 20% of total blood
supply eventhough they are 1-2 % of pancreatic mass. Centrally in the
islets cells are the B cells – secrete insulin (60-80% of cells)
peripherally are the cells which secrete glucagon(15-20%) Somatostatin
and Pancreatic polypeptide(15-20%).
Physiology of pancreas:
Both endocrine and exocrine functions.
8In the exocrine part the acinar cells secrete enzymes and
intercalated duct cells secrete electrolytes.Its secretion is regulated by
secretin CCK and  by reflux mechanism.
All enzymes are secreted as inactive proenzymes these
(Trypsinogen ) are activated by intestinal enterokinase (Enteropeptidase)
into active Trypsin. Inturn Trypsin is the activator of other enzymes
secreted by pancreas namely Chymotrypsinogen,  Phospholipase A2 and
other pro enzymes and this reaction is autocatalytic once initiated.
Normally pancreas contains Trypsin inhibitors.
Phospholipase A2 removes a fatty acid from lecithin to form
hydro lecithin which damages cell membrane. This enzyme is the reason
for the destruction of pancreatic tissue and fat necrosis. In acute
pancreatitis only a small amount of pancreatic enzymes leaks into the
circulation but in active inflammation of the gland this level increases
markedly and they acts as markers and have in diagnosing acute
pancreatitis.
Acute pancreatitis:
Etiology:
Majority of cases of acute pancreatitis are due to alcohol and gall
stones (80-90%). In United States of America , alcohol is deemed as
9cause of majority of cases, where in Asia and United Kingdom the most
common cause is gall stones. In India even though gall stone is
considered as the most common cause, ethanol induced pancreatitis is
on rise particularly in south India. Idiopathic acute pancreatitis
constitute upto 30% of cases. Other causes are infection, systemic
disease, trauma, hereditary and others.
Causes:
Obstructive causes:
Biliary calculi (gall bladder and CBD calculi)
Tumours of pancreas and ampulla
Foreign bodies at the ampulla
Other rare causes:
Diverticulum in duodenum
Choledochocele
Pancreatic divisum with constricted and small accessory duct
Drug induced:
Alcohol-Ethanol, Methanol
Sodium Valproate, Estrogen
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Anti cancer drugs- Azathioprine, Mercapto purine
Antibiotics- Metronidazole Pentamidine Tetra cycline
Sulphonamides
others-Cimetidine, Furosemide, Acetaminophen
Idiopathic
Hereditary
ERCP induced
Hypercalcemia
Hyperlipidemia
Infection –both bacterial and viral
Vasculitis-PAN, SLE
Others:Cystic fibrosis
Crohn’s disease
Pathogenesis:
Mechanism: Obstructive
                       Toxic
                       Genetic
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Obstructive:
Mechanism of pancreatic injury by bile stone passage is unclear
Theories:
In 1901, Opies theory, bile retrograde reflux from CBD into
MPD through a common channel.It has been proved wrong due to the
absence of long common channel, pressure in MPD exceeds that in
CBD and so only pancreatic juice only can enter bile duct.
Duodenal reflux theory:
Stone passing through the sphincter of oddi dilated and loosens
the sphincter thereby allowing reflux into the CBD, which is also
disproved by the absence of pancreatitis with all patients undergoing
sphincterotomy and sphincter incompetence.
Ductal hypertension theory:
Bile stone obstructing the MPD secretion collect in the duct and
disrupt and enzymes leak out into the parenchyma, but only zymogen
and inactive form of enzymes. It is possible that ductal hypertension has
other effects that cause intraductal and parenchymal activation of
enzymes.
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Toxic:
Acinar cells are affected first. But the mechanism of injury by
alcohol and drugs is not known. Calcium activates and can increase the
activation of other intra cellular enzymes.
First attack of pancreatitis occurs early in life. Family history is
present. Genetic mutation is cationic Trypsinogen gene produces
Trypsinogen that is resistant to Trypsin inhibitors and auto activates
itself. Genetic mutation in the secretory Trypsin inhibitor SPINK 1 gene
leading to inactive or defective Trypsin inhibitor
So, Trypsinogen is activated within the cell. Also seen in cystic
fibrosis patients(CFTR) CFTR mutations are seen in cases of idiopathic
acute pancreatitis.
Acinar cell:
It is a very active cell line. Protein synthesis producing pancreatic
and zymogen enzymes are secreted by acinar cells and are assembled in
rough endoplasmic reticulum which gives them their tertiary structure.
Then transported to golgi complex where packaging in membrane bound
vesicles occur.At the luminal end vesicles fuse with plasma lemma and
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by contraction of  active cytoskeleton the process of exocytosis,
enzymes are released.
Lysosomal hydrolases which can activate these zymogens are
secluded and separated by post translational modification of 6 mannose
phosphorylation and are included in separate vesicles.
Factors preventing activation of enzymes:
Enzymes are secreted in zymogen form and are transported in
membrane bound vesicles  and transported along with inactivators like
trypsin inactivator.
Segregation of lysosomal hydrolases which activates zymogen
like cathepsin B into separate vesicles.
Changes in acinar cells in pancreatitis:
Diet induced model-Choline deficient diet with Ethionine
(Lombardi et al)1975
Fusion of zymogen granules in lysosomes takes place.
Secretogogue induced model-CCK or its synthetic form Cerulin
iv(lamp et al1977).
Sense defective post transcriptional modification in golgi bodies.
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Ligation of  Bilio pancreatic duct mode-(Seninger et al)
Here, the secreted zymogens are again taken up due to obstruction
of duct into the lysosomes.Protein synthesis and secretions are normal.
Colocalisation and enzymatic activation
Pancreatic activation within acinar cells is seen in all models of
pancreatitis.It is being held that intraacinar activation of enzymes is the
critical event in pancreatitis leading to injury of acinar
cells.Colocalisation phenomenon is still the valid hypothesis explaining
enzyme activation.Some by this theory co localisation of zymogen
granules and cathepsin B activates trypsinogen to trypsin and it in turn
activates other enzymes.
Intracellular mediators in pancreatitis:
These include
 Cacium
Protein kinase c
Protein kinase a
Phosphor ionositide 3 kinase
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Model in CCK induced pancreatitis
                         CCK
       Attaches to CCK A low affinity receptors             adenylate cyclase
         Phospholipase C activation                                         CAMP
Phospho ionositol                 di acyl glycerol 2 phosphate
                Phosphoinositol 3                                       protein kinase A
                           Calcium             proteinkinase c
           1)  Activation of transcription factors NFKB and
Secretion of inflammatory mediators tyrosine kinase activation
           2)  PI3K leads to co localisation and enzyme activation
           3)  Inhibition of secretion.
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Secretory determinants:
                      Causes like alcohol bile stone
                     Acinar cell injury including
                     colocalisation cell injury
                   production of inflammatory factors
                            Acute pancreatitis
Organ dysfunction                              chronic pancreatitis
And systemic events.
PATHOPHYSIOLOGY OF ACUTE PANCREATITIS
Three important events in pathophysiology of acute pancreatitis
are,
Changes in circulation of pancreas
Inflammatory response(both local and systemic)
Increase in permeability of  gut.
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Changes in circulation of pancreas
Changes are,
                   Vasoconstriction
                    Capillary stasis
                    Oxygen saturation decreases
                    Ischemia
Reperfusion injury plays an important role in the pathogenesis of
pancreatitis. Reperfusion causes vasodilation and initiates production of
oxygen free radicals.
The balance between nitric oxide and endothelin is an important
determinant and the induction of inducible Nitric oxide Synthase may
be a therapeutic target in patients with pancreatitis.
AMYLIN
Amylin is a polypeptide secreted by beta cells causes
hypoperfusion to exocrine areas in pancreas and it’s values are elevated
in setting of acute pancreatitis.
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RENIN ANGIOTENSIN SYSTEM
Renin angiotensin system also has been found to be upregulated
in pancreatitis,but the value of angiotensin inhibitors in pancreatitis in
underway in experimental trials.
Local and systemic inflammatory response
       Etiologic stimuli
Enzymes Inflammation
Ischemia                inflammatory cells
Cytokines
                                                 and chemokines
                                                 Neurokines
Acinar cells that are injured by the etiologic stimuli creates
oxygen free radicals that destroys other cell’s membrane and leads to the
release of chemoattractive substances.
This is proved by the finding of increased levels of oxygen free
radicals and antioxidants(like beta-carotene).
ACINAR CELL
ENZYME
ACTIVATION
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Next step is the migration of leukocytes into the region of
inflammation and is brought about by adhesion molecules like ICAM-1,
which is a powerful  agent for attraction of neutrophils.
Neutrophils are the first cells to enter the field and their product
PMN elastase is increased as one of the earliest markers in acute
pancreatitis.
Neopterin is also raised but it is a late marker as it is secreted by
macrophages which reach the field late in the course of disease.
Cytokines
Cytokine release is the next step in the inflammatory reaction and
they are secreted by different types of cells and are chemically low
molecular weight proteins.
They have pleotrophic functions and act on different types of cells
and many of them share their biological functions.
Different cytokines that are elevated in pancreatitis and
thereby,can be used as markers of severity are,
          Tumor necrosis factor-alpha
          IL-6
            IL-1receptor antagonist
            IL-10
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TNF-alpha
TNF-alpha is a early marker of severity but is cleared rapidly by
the liver. So instead, TNF-a receptor is used for this purpose.
IL-1
IL-1b is a mediator for inflammation raises along with it’s
receptor and it’s converting enzyme which cleaves it to it’s active form.
IL-6
IL-6 is secreted by different types of cells like macrophages,
monocytes , smooth muscle and endothelium.
It is one of the early severity marker for pancreatitis and it’s elevation
correlates with that of Phospholipase  A2.
It is the main stimulus for the production of acute phase proteins
in the liver and so is elevated before the levels of C-reactive protein.
IL-10
IL-10 is anti-inflammatory and is so protective in acute
pancreatitis.It increases in the first 24 hrs and has a steady decline
thereafter.
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HGF-
Hepatocyte growth factor is a Organotrophic factor that prevents
apoptosis of cells and thereby protects the pancreatitis.
PAF-
Platelet activating factor activates platelets,and increases
endothelial permeability and thereby leads to hypotension, hypovolemia
and ischemia of organ systems.
It is released by the action of Phospholipase A2 on the cell
membranes.
It has been found as the therapeutic target for patients with acute
pancreatitis.
The level of cytokines that correlate with the incidence of
Multiple organ dysfunction syndrome (MODS).
GUT PERMEABILITY IN PANCREATITIS
Intestine also has a role in pathogenesis of pancreatitis and occurs
at 72 hrs from the symptom onset.
Low intramucosal PH in bowel shows the damage occured to the
intestinal mucosa and denotes intestinal mucosa and it correlates with
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parenteral nutrition and malnutrition specifically to the gut mucosal
cells.
Microscopically, reduction in height of villi and low mast cell
number is seen in small intestine in cases of pancreatic necrosis.
This leads to the translocation of bacteria occurs through the
intestinal mucosa and is responsible for the infection of the pancreatic
necrosis.
Different studies hold different opinions in whether translocation
of endotoxins or bacteria occurs.
\SYSTEMIC INFLAMMATION
In necrotising pancreatitis,due to acinar cell damage leakage of
cytokines occur that enter the general circulation and leads to the
syndrome of SIRS ending in the failure of organ systems called Multiple
organ dysfunction syndrome.
Definition for systemic inflammatory response syndrome
Any two of following criteria amounts to SIRS,
Rectal temperature > 38°C or < 36°C
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Heart rate > 90 bpm
Respiratory rate > 20 breaths/min or PaCO2< 32mmHg
White blood cell count > 12 000/cu.mm or < 4000/cu.mm or 10%
immature cell forms.
Definition of Sepsis
Infection and associated Systemic inflammatory response
syndrome
Definition of Severe sepsis
Hemodynamic compromise and sepsis
Definition of multiple organ dysfunction syndrome
Failure of more than one organ system with inability to sustain
homeostatic mechanisms.
24
                                  Development of MODS
Injury to the pancreas
                       Systemic inflammatory response syndrome
                              Multiple organ dysfunction syndrome
Translocation of bacteria from gut
Pancreas infected                                         Other secondary infections
                                 Systemic sepsis/secondary MODS
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PATHOPHYSIOLOGY OF ALCOHOLIC AND TOXIC
PANCREATITIS
   Inhibits acinar secretion, Oxidative
                                                    Stress,  Tubular dysfunction
Uncouples oxidative phosphorylation
 Increasescell  permeability
Increases lysosome fragility
Decreased apoptosis
Increases necrosis
                                                 Transcription of NF-kB Increases
cytokine secretion
CLINICAL FEATURES:
Acute pancreatitis is equally common in men and women,but
uncommon in children. Mostly occurs in elderly patients in their sixth
decade of life. Epigastric pain with sudden onset increasing in severity,
boring in character, radiating to back with patient taking a leaning
forward posture is classical of pancreatitis. Vomiting may be present.
Clues to etiology include an alcoholic binge before the onset of
pain being a marker to alcoholic pancreatitis, jaundice, if present
indicates gall stone pancreatitis and positive family history of
pancreatitis is towards a hereditary pathology.
Mechanisms by
which
drugs,toxins and
alcohol causes
pancreatitis.
26
Patients in severe end of the spectrum have multiple organ
dysfunction syndrome or systemic inflammatory response syndrome.
These patients present with high fever, altered mentation,shock  and
Acute respiratory distress syndrome(ARDS). Ecchymotic lesion in the
umbilical region is called CULLEN’S SIGN and in the flanks is GREY
TURNER’S SIGN are uncommon and are seen in hemorrhagic
pancreatitis.
These signs are seen only in  3-5% of cases but when seen are
associated with 35% mortality.
OTHER SIGNS
Eye signs are Arcus lipoides in hyperlipedemic cases of
pancreatitis,Band Keratopathy in hypercalcemia, rarely retinal
examination shows Purtscher’s retinopathy.Panniculitis(subcutaneous
fat necrosis) and polyarthritis can be seen in autoimmune cases.
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                                   History , exam, laboratory values
Acute pancreatitis
Regular alcohol             Hypercalcemia                        cholelithiasis
Abuse(>50g/d)             Hyperlipidemia                     Choledocholithiasis
Alcoholicpancreatitis        Metabolic                           Biliary pancreatitis
                                              No
                                Strong family history,drug history
                                    autoimmune history
Drug induced/ hereditary                             idiopathic pancreatitis
Autoimmune pancreatitis
28
DIAGNOSIS OF PANCREATITIS
Laboratory investigations can support the diagnosis of acute
pancreatis. Radiology investigations  can confirm the diagnosis.
SERUM AMYLASE
Serum  amylase (1,4-a-D-glucan glucanohydrolase) is a digestive
enzyme secreted from acinar cells that breaks the internal alpha-1,4
bonds  in  sugars during digestion.
 Due to inflammation of the gland, secretion of amylase into
pancreatic juice is defective leading to leak of the enzyme into the
surrounding parenchyma and gets absorbed into circulation.
Levels start to rise after 2 hours, peak levels are attained at 48
hours, and fall to baseline in 4 to 5 days.
Serum level of amylase has no bearing in finding the etiology of
AP and it also correlate with the severity of the disease.
Limitations are,
1 If done after days of the initial inflammation, it might have
fallen back to the baseline values.
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2  Hypertriglyceridemia, if present as the cause, secretes a
inhibiting substance that prevents the raise of amylase levels in which
case serial dilutions of the test is needed.
3 In alcoholic Pancreatitis,due to damage of the acinar cells
amylase secretion is defective.
Causes of Increased Serum Amylase Activity
Other Pancreatic diseases
Acute pancreatitis(all types and etiologies)
Pancreatic cancer
Abdominal emergencies
Acute Cholecystitis
Common bile duct obstruction
Perforated viscous
Intestinal ischemia
Acute appendicitis
Ruptured ectopic pregnancy and acute salpingitis
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Salivary gland diseases
Renal insufficiency
Macroamylasemia
Diabetic ketoacidosis
HIV infection/AIDS
Sphincter Oddi stenosis or spasm
Drugs: Morphine
Specificity of the test is only 88% due to presence of other causes
of amylase elevation,but it is raised to 90% when  the level is more than
three t imes normal.
Isoenzymes of  Pancreatic amylase (p-isoamylase) normally raises
in acute pancreatitis  to more than three times normal.
It has 90% sensitivity and 92% specificity.But increased levels of
p-isoamylase is also seen  in intestinal perforation,renal failure and
ketoacidosis in diabetes.
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Amylase/C reatinine clearance ratio is elevated to upto 10%
from its normal value of 3% in acute pancreatitis, but this test is also not
specific to AP,but it can be useful in differentiating macroamylasemia
where urinary excretion of amylase is not elevated.
SERUM LIPASE
Serum lipase (Triacylglycerol Acylhydrolase) is also a product of
acinar cells which breaks glycerol esters in  fatty acids during digestion.
Values of  lipase increases 6 hours of inflammation and reaches
its peak at 24 hours but remains there for 8-13days after which it starts
to decline .
Sensitivity and specificity of lipase are 94% and 96% respectively
if the values are 2 to 3 times normal.
It can also be seen in other causes but is more specific than
amylase in diagnosing pancreatitis.
 Those conditions with Hyperlipasemia are,
Peptic ulcer disease
Small bowel obstruction
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Hypertriglyceridemia
Diabetic ketoacidosis
Renal insufficiency.
Crohn’s disease
Autoimmune diseases like Sarcoidosis
COMBINED AMYLASE AND LIPASE
Combined Amylase and lipase estimations has failed to
increase the accuracy than both the tests done alone. However it is being
done often in clinical setting. A serum lipase level and/or with radiology
investigations can give the diagnosis in 32% of patients with normal
amylase levels and pancreatitis.
TRYPSINOGEN
Trypsinogen ( 25-kDa pancreatic protease) is also secreted by
pancreas and has two isoforms 1 & 2. Trypsinogen-2 is elevated in both
blood and urine upto 12 fold.
Sensitivity and specificity are 93% and 95.5% respectively, but
the negative predictive value is almost 100% and so a negative test rules
out the disease.The test is yet to be validated in international trials.
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Other upcoming tests for diagnosing AP are,
Serum immunoreactive trypsin,
PMN elastase
Chymotrypsin
Phospholipase A2
Pancreatic activated protein(PAP).
Alpha 2-macroglobulin
COMPLICATIONS OF ACUTE PANCREATITIS
Severe Acute Pancreatitis
According to the Atlanta classification,severe pancreatitis is defined
as presence of local complications or systemic complications like Organ
failure.
Fluid Collections
     They are situated near the pancreas or in the substance of pancreatic
parenchyma.They may develop into pseudocyst or may get infected to
form an abscess.
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Necrotising Pancreatitis
       Due to ischemia,the area of pancreatic parenchyma becomes
nonviable and forms area of necrosis.By definition, it should be more
than 3cm in imaging studies.
Pancreatic Abscess
       It is the collection of pus in and around the pancreas in the
retroperitoneum and it may or maynot contain necrosis.
MODS and Organ failure
It may de defined  by the presence of hemodynamic
compromise,(Systolic BP-less than 90 mmhg),ARDS with PaO2 < 60
mmhg,Renal failure requiring dialysis or creatinine >2 or severe GI
bleed.
RADIOLOGY IN ACUTE PANCREATITIS
The use of radiology in acute pancreatitis is to
                       to confirm the diagnosis
                       to identify the possible etiology of pancreatitis(eg,biliary)
                       to assess the grade and local complications.
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Ultrasound
It is usually not used as primary mode of imaging (due to poor
imaging of pancreas because of intervening bowel gas) in acute
pancreatitis other than cases with suspicion of biliary etiology for
pancreatitis where gall stones can be ascertained by ultrasonography.
 Findings are,
Hypoechoic gland or parts of gland
Edematous or enlarged gland
Pancreatic ascites
Areas of hemorrhage and necrosis
Computed tomography
It is the most important radiographic investigationin the diagnosis
of pancreatitis and it also rules out other causes of acute abdomen like
hollow viscus perforation and other inflammatory conditions.
It also helps in grading the disease thereby gives the severity of
the diseaseand identifies the complications.
36
Findings that are suggestive of the diagnosis are,
Enlargement  and edema of the pancreas
Heterodense parenchyma
Peripancreatic fat stranding
Obliteration of  fat planes around the pancreas
Peripancreatic and extrapancreatic fluid collections.
A focal or diffuse area of nonenhancing portion of  parenchyma
on examination with oral and i.v contrast is the classical finding for
pancreatic necrosis in CT examination.
Magnetic resonance imaging
MRI with the advanced technology of  Magnetic retrograde
pancreaticocholangiography is more extensively used in pancreatitis but
its utility in acute pancreatitis is minimal.
MRCP  detects severity of pancreatitis and is equivalent to CT
severity index in this regard. It can also give pancreatic necrosis as good
as a CECT.
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It is superior to all modalities in
Pancreatic duct changes and anatomy
Gall stones and CBD stones.
It can be used in patients with renal insufficiency where CECT
cannot be used as Gadolinium,contrast used in MRI is not nephrotoxic.
Endoscopic retrograde cholangiopancreatography
It has no role in acute pancreatitis except being used to remove
CBD stones with sphincterotomy and to delineate main pancreatic duct
anatomy in unresolved and recurrent pancreatitis cases.
ASSESSMENT OF SEVERITY IN ACUTE PANCREATITIS
BACKGROUND
In clinical setting, acute pancreatitis shows great variations.
Majority of patients have a self limiting and mild disease(85%) and they
need only general therapy and can be treated in surgical wards. The
remaining 15% patients have either local or systemic complications and
the disease is frequently fatal due to multiple organ dysfunction
syndrome.
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In 1992 an expert group in the Atlanta classification gave the
definition for severe cases in pancreatitis as failure of one or more
organs and/or  locally complicated disease with pseudocyst, nacrosis or
abscess.
These patients will need continuous monitoring in a intensive care
unit and may need surgery like necrosectomy for pancreatic necrosis or
abscess drainage in pancreatic abscess.
From 1970s since ranson devised his prognostic scoring system in
pancreatitis,the past four decades have seen multiple comparison studies
between scoring systems (clinical,biochemical ,radiologic) through
multiple studies.
Definitions in acute pancreatitis given by Atlanta classification in
1992 have been widely accepted and has increased the accuracy of
evaluating the different prognostic markers against each other.
From the understanding of pathophysiology of acute pancreatitis,
it is known that only the initial phase of the disease is caused by
enzymes released and after 72 hrs, the disease becomes a systemic
inflammation and is independent of initiating the disease and causes
SIRS and MODS.
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So, treatment modalities instituted before 72 hrs of initiation can
have significant effect in improving the morbidity and mortality rates.
Therapy measures that could be advantageous if started early,
within 72 hrs include,
1. antibiotic prophylaxis in infected necrotic pancreatitis
2. early enteral nutrition could reduce complications when
compared to parenteral nutrition.
3. endoscopic sphincterotomy may help patients with gallstone
pancreatitis
 4. immunomodulators and cytokine inhibitors may have a role.
CLINICAL SCORING SYSTEMS
Some clinical signs if present may indicate worse prognosis like,
 Fever
 Tetany
 Palpable abdominal mass
 Cullen’s sign and Grey Turner’s sign
 Pleural effusion
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These are not specific enough to predict severe acute pancreatitis
and so scoring systems are sought.
Ranson score and Glascow score are the multivariable models
where 8-11 different variables are assessed.the main difference between
the two is that Ranson’s score is described mainly for alcoholic
pancreatitis whereas, glascow’s score is effective in pancreatitis due to
all etiology.
Limitations of these scoring methods
1.Score can be given only after 48hrs after two serial values of the
variables are assessed which is the golden hour in acute pancreatitis
when treatment if instituted are effective.
2.these scores have high negative predictive value(90%) but poor
positive predictive value(40-50%)  and so they can only be used to rule
out patients who donot have severe disease.
3.there is no followup criteria and so course of the disease cannot
be studied.
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Ranson’s scoring system for the prognostic evaluation of acute
pancreatitis.
Severe pancreatitis is defined by the presence of three or more
criteria.
At admission
Age > 55 years
White blood cells > 16 000/mm3
Lactate dehydrogenase > 350 U/L
Aspartate aminotransferase > 250 U/L
Glucose > 200 mg/dL
Within 48 hour
Hematocrit decrease > 10%
Blood urea nitrogen increase > 5mg/dL
Serum calcium < 8mg/dL
PaO2 < 60mmHg
Base deficit > 4 mEq/L
Fluid sequestration >6L
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Glasgow scoring system for the prognostic evaluation of acute
pancreatitis during initial 48 hours.
Severe pancreatitis is defined by the presence of three or more
criteria.
White blood cell > 15 000/mm3
Glucose > 10 mmol/L (no history of diabetes)
Serum urea > 16 mmol/L
PaO2 < 60mmHg
Serum calcium < 2.0 mmol/L
Aspartate aminotransferase/alanine aminotransferase > 250 U/L
Lactate dehydrogenase > 600 U/L
Albumin < 3.2 g/dL
APACHE II SCORE
APACHE II (acute physiology and chronic health evaluation
score II)score was originally designed to give the possibility of death in
ICU setting due to variety of diseases.
It can be calculated at admission and so is more useful than
ranson’s score. But, it also has low positive predictive value like the
previous scores.
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An increasing score may indicate severe disease and declining
values indicate mild disease since serial scoring is possible.
Obesity is found to have deterrant effect on course of the disease
and so BMI(body mass index) is added to the score recently and the
score is called APACHE-O score.
BIOCHEMICAL MARKERS OF SEVERITY.
Protease activation-markers.
Activation of proteases  happens in acute pancreatitis in early
steps and activation of trypsinogen occurs to form trypsin which
activates other proteases like
          PhospholipaseA2
          Procarboxypeptidase B
During activation of proteases, a peptide moiety is released from
the enzyme and is called Activation peptide.It’s level measured in blood
and urine gives the local damage to the gland and thereby,the severity of
the disease.
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TAP-trypsinogen activating peptide
It reaches it’s peak level at 24 hrs and falls to baseline quickly
within 3 days which restricts it’s utility in prognostifying the disease.
This test has inconsistent sensitivity and specificity in multiple
studies and presently can be used only in cases within 24 hrs.
CAPAP-Procarboxy peptidase activation peptide.
It is more stable easy to measure than TAP,but it also falls very
rapidly and the test can be used only in the first 24-48 hrs.
PLAP-phospholipase activation peptide
This could be useful marker in the future because, it is released
both pancreas and granulocytes and so can give the measure of both
events of pathogenesis-enzyme activation and inflammatory reaction.
Inflammatory reaction-markers
In all types of pancreatitis, secondary event in pathogenesis is
inflammation which releases cytokines and other mediators like oxygen
free radicals and interleukins(IL-8).
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These lead to attraction of polymorphonuclear cells and
macrophages/lymphocytes and they release more cytokines and
proteases.If excessive stimulation of  inflammatory mechanisms
occur,SIRS ensues.
Major mediators of inflammation that are studied as markers of
severity are,
                   Tumor necrosis factor(TNF)
                    IL-6 and IL-8
                    PMN elastase
                    C-reactive protein(CRP)
These are essentially nonspecific to pancreatitis and are markers
of inflammation.
PMN elastase
This marker is positive even on the first day of disease and starts
falling after 48 hrs and it’s value in severity is on the first day of
pancreatitis.
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It has high sensitivity and specificity of 85-95% and is measured by
immunoagglutination.
Interleukins
They also increase within 24 hrs and so is first day marker of
severity in acute pancreatitis
TNF(Tumor necrosis factor)
It is known that TNF is released in a inconsistent and intermittent
way and so serum levels of soluble TNF receptors have become test to
differentiate mild from severe disease.
It reaches specifically high levels in patients develop organ
failure.
CRP-C reactive protein
It is the most widely available and cost effective marker and is
synthesized in the liver by action of IL-6 and IL-1. Serum levels rise
slowly and reach peak values between 48-72 hrs.
Serum levels more than 100mg/dl-150mg/dl is considered
positive.
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Sensitivity and specificity are more than the clinical scores,but is
lower than Interleukins and PMN elastase.
It also predicts necrotising pancreatitis with high sensitivity.
It can also function as a marker used to decide on the necessity of
contrast enhanced CT scan.
 Inspite of all these considerations, CRP reaches it’s peak at only
48-72 hrs and so cannot determine the severity in the therapeutic
window of pancreatitis(first 72 hrs).
Imaging in severity assessment
CTSI:
CT is the most efficient and reliable method for evaluating
patients with acute pancreatitis. It is justified in doing CT in acute
pancreatitis because it can confirm the diagnosis as well it can give early
assessment os disease severity.
It can also be use to detect and follow up life threatening local
complications and it can rule out other disorders presenting like acute
pancreatitis.
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Oral contrast agent is given just before scanning and IV non ionic
contrast 3-4 ml/sec bolus injection. CT acquisition starts after 60 s of IV
contrast injection.
Helical CT with 5 mm axial collination –two phase acquisition
technique- arterial and portal venous phase is used.
Normal pancreas-  40 to 50 HU
Arterial phase- 150 HU
Portal phase- 100 HU
Normal variation 10-20 HU can be there.
In acute pancreatitis, small ill defined heterogenous collection
develop , with 20 -40 HU attenuation values and represents a
combination of inflammatory exudate, fat necrosis and haemorrhage.
Diseased pancreas failed to enhance during IV contrast
administration and it is the most and consistent and distinguishing
feature of  ischemia and and pancreatic necrosis and is the classical CT
feature to give the necrosis and therby severity of outcome and
protracted clinical course.
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It is known that pancreatic necrosis is directly related to mortality
2- 10% and recently it is found to be the phenomenon occurring at the
beginning of acute attack rather than being the end result of severe
panctreatitis and thus have become one of the grave prognostic indicator
of outcome in patients with acute pancreatitis. The first CT based
grading was based on plain CT imaging and gave mortality and
morbidity of 14%  and 54% for D and E and no mortality and 4%
morbidity for A,B,C.
Balthazar and Ranson’s CT severity Index
Description Score
Pancreas normal 0
Enlarged gland,necrosis less than 3 cm, fluid collection in
the pancreatic parenchyma
1
Inflammatory changes ,peripancreatic changes 2
Fluid collection around the pancreas(single) 3
Multiple collections around pancreas or abscess formation 4
Necrosis Score
None 0
<30% 2
30-50% 4
>50% 6
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DEMERITS:
Plain CT could not give pancreatic necrosis as no contrast
enhancement was used.
Inability to predict morbidity in fluid collection most of which
resolved spontaneously but are given as high grade in plain CT index.
CTSI: included IV contrast enhancement and incorporated
necrosis score in the total CTSI score patients with normal enhancing
pancreas 0% mortality and 6% morbidity, but those with areas of
necrosis had 82% morbidity and 23% mortality.
Morbidity Mortality
0-2 4 0
3-6 35 6
7-10 17 92
Limitation of CTSI:
Most of them are due to poor techniques, motion artifacts, lack of
iv contrast administration and poor quality studies.IV contrast cannot be
given in allergic patients and renal failure.
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Early necrosis, ischemic finding at 2-3 days are hard to find  and
so all patients with suspicious and equivocal findings and with large
pancreatic and peri pancreatic collection should undergo repeat CT scan
as follow up.
Pancreatic exudate extravasated  can obscure the changes in
retroperitoneum and can present even without recognised changes in
pancreatic parenchyma and may need a needle aspiration to
differentiate.
TREATMENT GUIDELINES IN ACUTE PANCREATITIS
CONSERVATIVE MANAGEMENT
Supportive care
Fluid replenishment is the cornerstone of treatment to correct
hypovolemic shock and other third space losses.
 Supplemental oxygen should be given during first day to all cases
and specially to patients on opiods for pain control.
Analgesia should be adequate.
Nil by mouth to provide bowel rest is important and the interval
after which oral diet can be resumed is controversial and is a topic of
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undergoing trials, most of which suggest early enteral feeding to prevent
changes in intestinal mucosa and thereby bacterial translocation.
Treatment in intensive care unit
Patients who need transfer to an intensive care unit are,
         a. Those with sustained hypotension and decreased oxygen
saturation and who doesnot respond to a bolus of i.v fluids.
         b.Patients with evidence of renal failure.
         c.Older patients with cardiac disease and patients with
respiratory fatigue.
         d.Patients who need continuous monitoring like patients on
pressor support and those who need dialysis.
Nutrition
Simple dictum is all patients who are nil per mouth for a week
will need nutritional support.
Enteral feeding is better than parenteral mode due to following
reasons.
 It prevents complications caused by TPN like hyperglycemia and
septicaemia.
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 It also prevents intestinal mucosal injury and thereby
translocation of bacteria from the gut.
Nasogastric tube feeding is found comparable to nasojejunal tube
feeding and is now advised as  mode of enteral nutrition.
Role of prophylactic antibiotics
Even if it is associated with organ failure,interstitial or edematous
pancreatitis doesnot show changes in morbidity and mortality with
prophylactic antibiotics.
But in cases of necrotising pancreatitis, all the six studies done
show improvement in mortality with prophylactic antibiotics and
decreased rate of infection of the pancreatic necrosis.
With the increasing use of antibiotic of wide spectrum like
carbapenems,fungal infection of pancreatic necrosis is on the rise.
Infected necrosis-management
It is known that if infected necrosis is suspected either by,
First 7 days-fever and leucocytosis
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           From 7-15days-if  fever and leukocytosis persist or if organ
failure persists beyond that time.
Infected necrosis is diagnosed by,
          Ultrasound or CT guided aspiration for gram staining and culture.
Reasons in support of aspiration are,
             It can give sensitivity of the organisms and so appropriate
antibiotics can be instituted.
             Since the prevalence of fungal infections is on the rise, broad
spectrum antibiotics should be avoided in patients with negative staining
and culture.
It has been advocated that surgical necrosectomy is indicated in
all patients with infected pancreatic necrosis which has been questioned
in the latest studies which advocate only antibiotics in the acute phase in
infected necrosis.
This can allow  the infection to settle and a more definitive single
stage procedure can be done in these cases.
 Alternatives to surgical necrosectomy in these cases are,
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             Minimally invasive necrosectomy
             Percutaneous catheter drainage, by multiple radiologically
placed catheters.
Pancreatic abscess is defined as the  liquefaction and infection of
already and secondary infection of a residual area of necrosed area of
pancreas or infection of a pseudocyst around the pancreas and it is
mostly treated by percutaneous drainage.
Sterile necrosis-management
In cases with sterile necrosis, early intervention in the first 2-3
weeks has been found to be a method to decrease the occurrence of
organ failure and outcome in patients with fever, leukocytosis and organ
failure.
But otherwise in patients with sterile necrosis, early necrosectomy
has been found to have negative consequences in the morbidity.
So, it is wise to wait atleast 3 weeks to allow the peripancreatic
inflammation to settle and to allow a onestage necrosectomy.
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Both percutaneous drainage in cases of necrotic collections and
surgical procedures like cysto-gastrostomy and cysto-jejunostomy in
cases of pseudocyst formation may be needed.
Pancreatic duct damage-treatment
It may be complete rupture of the duct-disconnected duct
syndrome or  partial rupture.
It is suggested by increase or persistence in size of collection in
CT scan.
Treatment-
          If no symptoms-no treatment
          If symptoms are present-increasing pain-ERCP done to document
duct damage and treatment is by nasojejunal feeding and Octreotide (to
decrease pancreatic secretions and to allow healing of the damaged duct.
Endoscopic stent placement is usually unsuccessful.
Biliary pancreatitis-role of sphincterotomy
It should be done early in the course of disease to be useful and
should be within 1 or 2 days.
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Patients who have early signs of organ failure are the most
benefitted group from sphincterotomy.
It is useful mostly due to preventing ascending cholangitis which
is the reason for organ failure.
Sphincterotomy is useful  due to the removal of Common Bile
Duct stones.
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TREATMENT ALGORITHM FOR BILIARY PANCREATITIS
                                         Diagnosed case of
                                         Acute pancreatitis
                                        Biliary etiology suspected
                                         ERCP and sphincterotomy
                                                 Within 3 days
                                            Severity assessment
Interstitial/mild pancreatitis                   necrotising/severe pancreatitis
Interval of 1 week(7days)                               supportive care in ICU
Lap cholecystectomy              1-3 DAYS             prophylactic antibiotics
a.necrosectomy                                           infected necrosis is diagnosed
b.retroperitoneal lavage                                           by guided aspiration
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INDICATIONS FOR SURGICAL TREATMENT IN ACUTE
PANCREATITIS
a. Infected pancreatic necrosis
b. when the diagnosis is uncertain
c. associated gall stones or CBD stones
d. if patient’s condition deteriorates inspite of supportive care.
Diagnosis is uncertain
In some cases diagnosis of acute pancreatitis  cannot be
ascertained inspite of good clinical exam and laboratory tests. CT is of
great help in those cases.
But in some rare cases, where diagnosis is uncertain, exploratory
laparotomy is done mainly to rule out surgically correctable disease.
In these cases, after ruling out other causes of acute abdomen,
            Sample of peritoneal fluid for amylase, lipase, cell count and
culture is taken.
              Pancreas is visualised-if found normal, left undisturbed.
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In cases of noninfected pancreatic necrosis with exudates, a
peritoneal dialysis catheter is left in the peritoneum in view of giving
peritonel lavage post operatively.
Infected pancreatic necrosis
As already seen,
A circumscribed collection of purulent material around the
pancreas is pancreatic abscess.
           Infected pancreatic necrosis is patchy or diffuse areas of
nonviable parenchyma in the pancreas.
Infection occurs by,
                  Bacteria from the colon through transmural route
                   Bacteria from the duodenum or biliary system
                   Hematogenous spread
Organisms are,
                        Enterococcus
                        Klebsiella
                        E.coli
                        Anerobes and fungi
              polymicrobial
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High suspicion is needed to diagnose infected necrosis,that too it
should be sought in all cases with deteriorating clinical status.
It cannot be diagnosed by any radiologic means, except in some
rare cases where air is seen in the pancreatic area and adjacent
retroperitoneum.
The only confirmatory test is guided aspiration and
staining/culture.
If percutaneous drainage fails, surgery is indicated,
                 a.   necrosectomy with open packing
                 b.    necrosectomy with closed drainage
                 c.   necrosectomy with continuous lesser sac lavage.
Debridement should encompass only already necrosed and
degraded tissue as excess of debridement may cause hemorrhage that is
troublesome.
Associated Biliary disease
Approach to biliary pancreatitis was to wait for 2 months after an
episode of acute pancreatitis.
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But this approach has lost it’s favour because frequent recurrences
occur after the initial episode and so nowadays, cholecystectomy with or
without CBD exploration and cholangiography is done safely after 3-6
days with classical open approach or minimally invasive method.
Before elective cholecystectomy, rate of recurrence of pancreatitis
is 45-55%,but after surgery it is reduced to 5%.
If suspicion of CBD stones exist, preop ERCP is done in view of
sphincterotomy and removal of stones.
Exception to this rule is ,
Severe Biliary pancreatitis patients whose clinical course is
prolonged but who are improving with signs of,
                                    a. Paralytic ileus
                                    b.Fluid collections
                                    c. ascites
In these patients, it is wiser to do a interval cholecystectomy after
4 weeks.
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Worsening clinical status
These patients fail to respond to conservative measures and there
clinical status is deteriorating.
It has been proved beyond doubt that,debridement and pancreatic
resection in these patients with no evidence of infected pancreatic
necrosis or biliary obstruction increases the mortality rates.
Therefore, conservative supportive measures are the line of
treatment in these patients currently.
CRP:
Acute phase proteins are systemic response to inflammation and it
is mediated by cytokines, Baumann and Gauldie 1994.
C reactive protein, discovered by Francis and Tillet, 1930 is one
of the acute phase proteins. Named so because it agglutinates some
members of Pneumococcus species binding to the C polysaccharide.
It was identified by Abernethy and Arey in 1941 as protein
crystallized by Mc carty 1947 and Anderson and Maccarty in 1950 gave
its medical applicability  in Rheumatic patients to find Rheumatic
activity.
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It belongs to the Pentraxin, protein family with a calcium
dependent ligand function . its electron microscope picture was given by
Osmand et al in 1977as containing five identical  subunits arranged in
pentagon ring structure.
Liver is the major site of production of CRP and other acute phase
proteins (Kushner and Feldman 1978). The major inducing cytokine is
IL 6(Castell et al 1989).Interleukin and TNF alpha are not independent
inducers of CRP synthesis but modulators(Kushner et al 1987, Taylor
et al 1989).
IL 6 is mainly induced by monocyte macrophage granular
leucocytes and many other types of cell and what makes it specific as
the marker of inflammation is till now no specific pro inflammatory
stimulus has been found for secretion of CRP by liver.
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                                               C reactive protein
   Apoptotic                                                                                 Bacteria
Cell membrane
              Phosphocholine                                               Activate classical
                                                                               Complement pathway
                                                 Binds to FCgRII
                                                   And FCgRI
                                        On leucocytes membrane
Increase phagocytosis
Release of inflammatory cytokines
Function of CRP could seem to be to provide
          1. Non specific innate immunity by protection against harmful
foreign molecules .
           2. Restoration of normal structures a function  by clearance of
injured apoptotic and necrotic host cells.
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CRP is the single commonly used marker in severity in pancreatitis and
it is a measure of hepatic acute phase response ( Wilson et al 1989).
Peak levels of CRP are reached only after 48-72 hours of the start
of inflammation and so its role is limited in early disease but it is
useful in follow up of disease (Neptolemos et al 2000, Puolakkainen
et al 1987).
CRP is also elevated in conditions like
Coronary heart disease,
 Insulin resistence,
Diabetes,
 Dental disorders,
 Smoking,
Over weight,
Obesity,
Alzheimers disease,
Rheumatois arthritis,
Cancer.
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PATIENTS AND METHODS:
50 Patients admitted to emergency ward, Stanley medical college
hospital, Royapuram Chennai from June 2011 to October 2012
diagnosed as acute pancreatitis ( ethanol induced) are selected for the
study, after through history which includes history of alcohol intake ),
clinical examination and basic laboratory investigations.
Diagnosis of acute alcoholic pancreatitis is made by,
Acute onset of epigastric boring pain radiating to the back with
history less than a day and absence of previous history of similar pain.
History of intake of alcohol is asked and patients affirmed are
included.
Biochemical confirmation by serum amylase ( >4 times normal)
and radiological investigation include USG abdomen and CT abdomen
with findings suggestive of pancreatitis.
EXCLUSION CRITERIA:
Patients with more than 1 day abdominal pain even if the
diagnosis is acute pancreatitis.
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Patients with acute on chronic pancreatitis as revealed by previous
history of pain or treatment.
Children < 14 years of age are not included in the study.
Patients with acute pancreatitis with gall stone disease , drug
induced pancreatitis and other causes of pancreatitis.
Patients with   disorders like rheumatoid arthritis, coronary artery
disease, diabetes mellitus ,Obesity etc.., which increase serum CRP
levels are excluded from the study.
Outcome measures:
Serial C reactive proteins levels were measured at 24, 48 and 72
hours were done after admission. Computed tomography with oral and
IV contrast agents was done at 72 hours after admission and CT severity
index (Balthazars and Ransons score) with CT grade and necrosis grade
was ascertained.
All patients with severe pancreatitis (as per the Atlanta
classification) were monitored and treated in surgical intensive care unit
with continuous cardiac and respiratory monitoring and regular
biochemical investigations including ABG while mild acute pancreatitis
were treated in our surgical ward.
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OBSERVATION AND RESULTS
Patients admitted to surgical ward with history and  clinical
examination suggestive of acute pancreatitis were selected.
After routine blood investigations,
           Serum amylase and Serum lipase values were done followed by
Ultrasonography of abdomen.
After confirmation of the diagnosis,only patients with history
suggestive of alcoholic pancreatitis and who didnot have any other
cause for pancreatitis are taken into the study.
Serial C reactive protein values were done at 24 hrs,48 hrs,72hrs
from the time of admission by standard method and is compared with
CT severity index which is assessed from contrast enhanced CT done at
3-5 days from the time of admission.
Necrosis score as given in the CTSI score is also compared and
it’s correlation with serum CRP values ascertained.
 Number of days of admission in the hospital is also recorded and
is used as a marker of morbidity of the disease.
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Significant Cutoff value for CRP was taken as 100mg/dl.
Different studies cited in my study has given different values as
significant (100 mg/dl and 150 mg/dl).In this study value of 100mg/dl
was taken as significant because it was given in multiple studies and
also correlated with our study results.
It has been already proved that peak levels of CRP are reached
after 48 hrs of the onset of pain and so, in this study also the 48 hrs CRP
values are compared with CTSI.
The current standard for assessment of severity and assessment of
necrosis in patients with acute pancreatitis is CT severity index assessed
by CECT with highest sensitivity and specificity and so is taken as the
standard in this study to find the value of CRP in this regard.
CTSI value which correlates with severity of disease is given in
multiple studies as more than or equal to 3,(i.e, presence of necrosis or if
no necrosis present, collections in and around pancreas) which is also
given as severe disease in Atlanta classification , is taken as significant
to differentiate mild from severe cases.
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Only one patient underwent necrosectomy in this study
(indication-infected necrosis)and the patient survived the disease and
was discharged on the 30th post operative day.
All patients with local complications and systemic disease are
treated in intensive care setting and continuous monitoring done.
C reactive protein is a nonspecific marker and acute phase protein
elevated in multiple inflammatory conditions and it is tried sincerely in
this study to eliminate patients with already raised CRP by history and
thorough clinical examination.
By assessing the correlation between CRP values and pancreatic
necrosis, the value of CRP values to discern patients who need a CECT
is ascertained.
Age distribution
Most of the patients included in the study are young to middle
aged males and among them, pancreatitis is most common in the 30-40
year group(4rd decade of life).
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Table 1.
    Age group      21-30yrs      31-40yrs      41-50yrs
    No of cases             8            27         15
Chart.1 shows the age distribution among the patients in the study.
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Etiological and gender distribution
Only male patients and alcohol induced pancreatitis patients are
taken into the study and so etiological and genderwise distribution were
not significant.
Serial CRP values distribution from time of admission.
CRP values continued to increase in patients with acute
pancreatitis and peaks at 72 hours after admission.
Table 2
         Time from admission(hours)     Average CRP values
                          24               61.52
                          48               71.43
                          72               80.24
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Chart.2 shows average CRP values serially from time of admission.
Average CRP values based on Age of patients
CRP values rise as the age of the group increases and highest
values are seen in older age group.
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Table 3.
Age group(yrs) Average CRP values(48 hrs)
                    21-30                 70.26
                    31-40                  75.62
                    41-50                  77.72
Chart.3 shows average CRP values(48 hrs) based on the age group.
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Significant CRP values vs Duration of hospital stay.
    Duration of hospital stay varied in different patients from 7days to
59 days(mean=26 days). Patients with CRP values >100mg/dl and
values <100mg/dl are correlated with days of hospital stay in patients.
Table 4.
         CRP values(mg/dl) Duration of hospital stay(days)
             <100 mg/dl                     12
             >100 mg/dl                     25.2
Chart.4 shows correlation of duration of hospital stay with
significant CRP values.
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Table 5 showing comparison of number of patients with significant
CRP values at 48 hrs (>100 mg/dl) vs CT severity index values (>3).
CRP value
>100mg/dl
(at 48 hrs)
CRP values <100
mg/dl
(at 48 hrs)
CTSI >3 (total score) 11 2
CTSI <3(total score) 8 29
CALCULATION:
Sensitivity
number of true positives /true positives +false negatives
sensitivity = 84.61%
Specificity
Number of true negatives/true negatives+false positives
specificity =78.37%
Positive predictive value((PPV)
Number of true positives/true positive+false positive
PPV =57.9%
Negative predictive value
Number of true negative/true negatives+false negatives
NPV=92.54%
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Table 6 showing comparison of number of patients with significant
CRP value (48 hrs) with presence or absence of necrosis.
CRP
values>100mg/dl
            (48 hrs)
CRP
values<100mg/dl
             (48 hrs)
Presence of necrosis
(necrosis score+)                5                 1
Absence of necrosis
(necrosis score 0)                 8                 36
Sensitivity =83.33%
Specificity =81.81%
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DISCUSSION
It is already known that CRP is a acute phase protein secreted by
liver in multiple inflammatory conditions and is a non specific marker.
With this background,the major object of this study is to find the
usefulness of Serum C reactive protein levels which is the most widely
available and cheap inflammatory marker (Rafaele Pezilli et al,) in
various aspects in setting of acute pancreatitis.
Of the 13 patients with severe acute pancreatitis as defined by
Atlanta classification, all patients had CT severity index more than equal
to 3 and so it is justified in using it as a standard to compare CRP values
and it is the current standard in this regard as shown by number of
studies.
As shown in other studies,peak values of CRP are reached at 48
hrs in our study and so values at 48 hrs are taken for the statistical
analysis for comparison against CTSI.
As given in the literature,most of the therapeutic modalities
employed  in acute pancreatitis are useful only if instituted before 48
hours and eventhough CRP level is sensitive in giving the severity of
disease,it cannot be considered as a very good indicator in this regard.
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Significant value CRP level is given as different in multiple
studies but, CRP level >100mg/dl as given in study by Meyer et al,
correlates with values obtained in our study and so is taken as
significant value for comparison.
Distribution of etiology and gender in pancreatitis could not be
studied as most of the study group is constituted by young to middle
aged males.
Average CRP values in subsequent decades of life is found to be
increasing with average values being 70.26 in 3rd decade and 77.72 in 5th
decade (chart 3) which also correlates with literature where it is stated
that CRP values increase with age and elevated values are seen in
old age.
Out of the 13 patients with severe disease,11 patients had CRP
values more than 100 mg/dl giving CRP at 48 hrs a Sensitivity and
Specificicity of  84.61% and 78.37% respectively,which correlates with
earlier studies and establishes CRP level as a severity marker in acute
pancreatitis with sensitivity and specificity better than  the scoring
systems (40-60%) as given by study by Gurleyik et al.(Table 5).
Out of 6 patients with necrotising pancreatitis with positive
necrosis score in CTSI, 5 patients had CRP values at 48 hours
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>100mg/dl giving CRP level sensitivity of 83.3% and specificity of
81.81% respectively (table 6)and by this data,it is established that CRP
level can be used as an indicator for necrosis and to decide on patients
with acute pancreatitis who need a CECT at 48-72 hours,since the
investigation(CECT) is expensive and not widely available.
Average number of days of all patients in this study is 26,with the
lowest being 7 days and the highest being 59 days. In patients with CRP
level<100mg/dl , average duration of stay in hospital is 12 days and in
patients with CRP values >100mg/dl, duration being 25.2 days (table 4)
thus giving a positive correlation between CRP levels and the duration
of stay in hospital and use of CRP level at 48 hrs as marker for the
duration of stay in hospital and thereby as a indicator of morbidity is
validated.
Some studies (Meyer et al) have done serial CRP values upto the
7 days and found that persistent elevation of Serum CRP values
correlate with incidence of local complications(pseudocyst,abscess
etc,)and the rate of need for surgery in the course of the disease,which
couldnot be studied in this study as CRP values are measured only upto
72 hours from the onset of pain.
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CONCLUSION
CRP as we know continues to be an acute phase reactant and a
non specific marker of inflammation due to multiple etiology and it’s
values increase with increasing age of the patient.
Eventhough CRP level has good sensitivity and specificity in
finding the patients with severe acute pancreatitis and it is better than
most of the clinical scoring systems in sensitivity and specificity, it a
poor marker in this regard as it’s peak values are reached only after 48-
72 hrs which is the therapeutic golden hour only within which
treatments if instituted are rewarding as given in the literature.
But according to this study, it can be useful in the following
regards.
 Increased values of CRP above the significant range correlates
positively with the occurrence of necrosis in pancreatitis and can be
used to decide on patients who need a CECT as this investigation is
expensive and is not widely available.
         It correlates positively with duration of stay of patients in hospital
thereby, giving the morbidity of acute pancreatitis.
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        Value of CRP levels in predicting the prognosis of the disease and
the need for surgery for local complications remains to be elucidated.
LIMITATIONS OF THE STUDY:
1.  Etiology could not be studied because the case group is ethanol
induced pancreatitis is only selected for the study.
2.  CRP being non specific marker of inflammation , exclusion of
patients with already raised CRP is only by thorough history
taking and questionnaire, but subclinical inflammatory conditions
raising serum CRP levels could not be ruled out.
3.   Clinical scoring systems were not included in this study.
4.  Gender and age distribution could not be studied because the case
group was all young and middle aged men and children < 14
years were excluded from the study.
5. Values were done only upto 72 hours and so the value of finding
CRP in finding the need for surgery and thereby morbidity in
patient by assessing CRP level at the end of 1 week could not be
done.
BIBLIOGRAPHY
1. Gunay gurleyik ,Seyfi Emir,Gamze Kilicogh,Alper Arman, article
titled computed tomography severity index APACHE II score and
serum CRP concentrations for prediting the severity of acute
pancreatitis. Jop. J pancreatitis (online 2005) , department of
surgery, department of surgery and department of radiology  hay
darpara numme education and research hospital.Istanbul turkey.
2. AD  meyer,MJ McMahon,Margaret Bowen,EH Cooper, article
titled C reactive protein an aid to assessment and monitoring of
acute pancreatitis j clinical pathol 1984 ,university , department
Of surgery general infirmary leeds and the unit for cancer
research , university of leeds .Leeds.
3. Raffacle pezzilli, Francesco Mansini, article titled assessment of
severity of acute pancreatitis a comparison between old and recent
modalities used to evaluate perennial problem. World journal of
gastroenterology1999, august.
4. Chun Chia Chen, Article titled serum markers in the early
assessment of acute pancreatitis which is most useful. J chin med
assoc 2004:67:439-441Division of gastroenterology department
of medicine . Taipei veterans general hospital and national Yang
ming university school of medicine, Taiwan.
 5.  Ahmed z, article titled clinical laboratory assessment of acute
pancreatitis. Clinica chimica acta (2005) 26-48, department of
surgery Manchester royal infirmary. Manchester .
 6. M.T Hamalainen , article titled do normal leucocyte and CRP on
admission exclude a life threatening attack of acute pancreatitis.
scandinarian  journal of surgery 91-352-356, department  of
surgery university of turkey, finland.
7. Clinical pancreatology for practising gastroenterologists and
surgeons / edited by J. Enrique Domínguez-Muñoz ; with
foreword by Peter Malfertheiner. PANCREATITIS AND ITS
COMPLICATIONS Edited by CHRIS E. FORSMARK, MD
University of Florida College of Medicine, Gainesville, FL
8. Diseases of the Pancreas Current Surgical Therapy  Edited by
Hans G. Beger, Ulm, Germany Seiki Matsuno, Sendai, Japan,
John L. Cameron, Baltimore, USA.
9. Marja-Leena Kylänpää-Bäck, ACUTE PANCREATITIS:
DIAGNOSIS AND ASSESSMENT OF SEVERITY WITH
MARKERS OF INFLAMMATION,Department of Surgery and
Clinical Chemistry, Helsinki University Central Hospital, and
Department of Bacteriology and Immunology, Haartman
Institute,Helsinki, Finland
10. Balthazar EJ, Freeny PC, Van Sonnenberg E. Imaging and
intervention in acute pancreatitis. Radiology 1994; 193:297-306.
11. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute
pancreatitis: value of CT in establishing prognosis. Radiology
1990; 174:331-336.
12. CANINE C-REACTIVE PROTEIN - a study on the applicability
of canine serum C-reactive Protein, Mads Kjelgaard-Hansen,
Ph.D.,Veterinary Clinical Pathology, Department of Small
Animal Clinical Sciences. The Royal Veterinary and Agricultural
University ,Frederiksberg, Denmark 2004.
13. M. Lempinen, P. Puolakkainen, E. Kemppainen, CLINICAL
VALUE OF SEVERITY MARKERS IN ACUTE
PANCREATITIS Department of Surgery, Helsinki University
Central Hospital, Helsinki, Finland, Scandinavian Journal of
Surgery 94: 118–123, 2005.
14. Mitchell S. Cappell, Acute Pancreatitis: Etiology, Clinical
Presentation, Diagnosis, and Therapy Division of
Gastroenterology, Department of Medicine, William Beaumont
Hospital, Royal oak, Clin N Am 92 (2008) 889–923.
 15. Ranson JHC. Diagnostic standards for acute pancreatitis. World J
Surg 1997; 21: 136–142.
 16. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute
pancreatitis. World J Surg 1997; 21: 130–135.
 17. Buchler M, Malfertheiner P, Schoetensack C, Beger HG (1986)
Sensitivity of antiproteases, complement factors and C-reactive
protein in detecting pancreatic necrosis.Results of a prospective
clinical study. Int J Pancreatol 1:227–235
18. Parimal Chowdhury, Priya Gupta, Pathophysiology of alcoholic
pancreatitis: An overview, World J Gastroenterol 2006 December
14; 12(46): 7421-7427
19. Gullermo Robles-Diaz,Fred S.Gorelick, alcohol and Acute
pancreatitis, Department of Medicine, Connecticut healthcare,
West Haven, Connecticut, Yale journal of Biology and Medicine,
1997, pp.77-87.
20. Shakelford’s Surgery of Alimentary Tract,5th edition ,edited by
Mark B.Orrhinger and Richard Heitmiller.
Role of C-reactive protein as a severity marker in acute
pancreatitis
Investigator: Dr. S.Vignesh, PGY2 – MS (Gen Surg)
Guide: Prof. Dr. Balamurugan, Chief, Unit S7.
__________________________________________________________________________
Patient Information Module
You are being invited to be a subject in this study.
Before you participate in this study, I am giving you the following
details about this trial, which includes the aims, methodology, intervention,
possible side effects, if any and outcomes:
All patients diagnosed with acute pancreatitis by history,clinical
examination and S.amylase measurement will be included in this study. A
detailed clinical history will be taken following a standardized proforma. A
detailed clinical examination will be made and relevant investigations,
including basic and special investigations will be done.CECT abdomen and
pelvis will be done  at the time and 72hrs after admission  and CTSI(CT
severity index ) according to BALTHAZAR grading will be found.All
patients will be examined thoroughly and APACHE 2(acute physiology and
chronic health evaluation score) will be ascertained.Serum CRP measurement
will be done at the time and then after 24 hrs,48hrs&72hrs of admission.CRP
values will be correlated with CTSI and APACHE 2 scoring.
The results arising from this study will be analyzed and used for
academic purposes. You will be given clear instructions at every step and you
are free to ask/ clarify any doubts. Your identity will remain confidential. You
are free to withdraw from this trial at any point of time, without any prior
notice &/ or without any medical or legal implications.
I request you to volunteer for this study.
Thanking You,
Investigator’s Sign      Patient’s Sign
(Dr. S.Vignesh.)             (Name:            )
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Informed Consent
Name: Age/ Sex: IP:
I herewith declare that I have been explained in a language fully
understood by me regarding the purpose of this study, methodology,
proposed intervention, plausible side effects, if any and sequelae.
I have been given an opportunity to discuss my doubts and I have
received the appropriate explanation.
I understand that my participation in this study is completely
voluntary and that I am free to withdraw from this study at anytime
without any prior notice &/ or without having my medical or legal rights
affected.
I permit the author and the research team full access to all my
records at any point, even if I have withdrawn from the study. However
my identity will not be revealed to any third party or publication.
I herewith permit the author and the research team to use the
results and conclusions arising from this study for any academic
purpose, including but not limited to dissertation/ thesis or publication
or presentation in any level.
Therefore, in my full conscience, I give consent to be included in
the study and to undergo any investigation or any intervention therein.
Patient’s Sign Investigator’s Sign
(Dr.S.Vignesh.)
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_________________________________________________________________________
Name:                                                    Age/ Sex:                          I.P. No.:
Address:                                                                                           Contact no:
D.O.A:                                                   D.O.S:                               D.O.D:
History and Physical:
Vital parameters:
Pulse rate
Blood pressure
Respiratory rate
Temperature
Investigations:
HEMAT
HB
PCV
RBC
TC
DC
PLT
ESR
RBS
FBS
PPBS
B.UREA
S.CREAT
S.Na+
S.K+
S.Cl-
S.HCO3-
S.AMYLASE
S.LIPASE
USG
CECT FINDINGS
CT SEVERITY
INDEX(BALTHAZAR
SCORING) AND
NECROSIS SCORE
time of admission:
     72 hrs:
	
CRP	LEVELS:																																																												
Time	of	admission	 	
24	hrs	 	
48	hrs	 	
72	hrs	 	
	
TREATMENT	GIVEN:		
		
TOTAL	DURATION	OF	HOSPITAL	STAY:			
DISCHARGE	NOTES:	
		
	
FOLLOW UP:
CT
grade
necr-
osis
total
1 48 male 6362 1 0 1
2 32 male 6764 3 0 3
3 48 male 6931 1 0 1
4 25 male 9795 2 0 2
5 32 male 11537 1 0 1
6 40 male 15993 3 4 7
7 45 male 15997 4 6 10
8 45 male 16388 2 0 2
9 30 male 18282 1 0 1
10 48 male 19607 2 0 2
11 35 male 20559 3 0 3
12 45 male 21144 1 0 1
13 24 male 21677 1 0 1
14 34 male 22444 2 0 2
15 34 male 26628 2 0 2
16 43 male 26635 1 0 1
17 32 male 31784 2 0 2
18 30 male 36450 1 0 1
19 38 male 36395 3 0 3
20 37 male 38254 2 0 2
21 28 male 37322 2 0 2
22 36 male 39206 3 2 5
23 32 male 39214 1 0 1
24 37 male 22536 2 2 4
25 31 male 27904 1 0 1
26 50 male 30091 3 2 5
27 34 male 30558 1 0 1
28 49 male 32774 1 0 1
29 35 male 33278 1 0 1
30 42 male 35095 1 0 1
31 43 male 37491 2 0 2
32 36 male 37469 1 0 1
33 37 male 50086 3 2 5
34 39 male 51069 2 0 2
88.5
33.2
118.9
72.6
19
139.7
56.6
57.6
48.5
110.4
56.7
120.2
90
30.9
127
68.8
93.2
127.3
42.7
79.5
78.4
162
79.2
105.7
110.9
159
34.9
66.5
110.8
40.2
120.4
33.2
135.8
106.8
39.7
100.4
79.2
31.7
104.3
59.8
24.5
123
17.2
136.2
48.5
42.8
59
52.3
99.2
48.8
106.3
90
67.8
15.3
102.3
53.7
11.3
120.1
42.9
87.6
31
38.9
146.8
28.3
61.9
92.1
122.5
39.6
31.6
118
137.6
76.2
101.3
102.2
27
110.2
98.5
29.7
80.2
85.6
18.2
111
36.9
123.4
47.2
46.2
98.5
130.9
21.3
Sekar
Loganathan
Mohan
56.2
78.1
110.2
30.6
57.3
Kumar
Amarnath
Gopinath
Purushothaman
Nagaraj
Muthukumar
Mani
Tamilselvan
Sivaji
Arunprasad
Anandhan
Muruganandham
Vidyakumar
Ramalingam
Sekar
Ramesh
Vishnu
Deva
Chandran
Gopi
Rajan
Kowshar
Arumugam
Sampath
Balakrishnan
Gopi
Baskar
Dharmaraj
Ashok
Kumar
Nelson
40.8
110.2
34.3
101.1
8
27
6
15
32.6
106.2
31.7
83.9
7
38
59
13
8
17
41
6
9
17
18
10
14
7
16
11
13
28
12
24
10
35
8
7
10
13
14
13
33
19
S.
No
Name Age Sex I.P.No
CRP
(24hrs)
CRP
(48hrs)
CRP
(72hrs)
no ofdays
admission
Balthazar's
score(CTSI)
35 48 male 45243 1 0 1
36 29 male 46040 2 0 2
37 31 male 955 1 0 1
38 36 male 2520 1 0 1
39 28 male 5252 1 0 1
40 40 male 25020 3 0 3
41 37 male 28928 1 0 1
42 35 male 33267 2 0 2
43 48 male 34231 2 0 2
44 30 male 39499 3 0 3
45 47 male 39529 1 0 1
46 33 male 40787 1 0 1
47 37 male 41382 2 0 2
48 33 male 42339 2 4 6
49 43 male 42361 1 0 1
50 40 male 48925 2 0 278.6
Veeran
Suresh
30.2
50.1
35.9
69.2
39
41.7
126.5
Raghu
Babu
43.2
118.1
17.9
47
67.1
146.4
109.7
37.8
34.4
121.5
59
110.9
67
35.7
59.5
130.2
48.6
103.2
38.6
110
17.8
45.8
57.8
28.9
101.2
35.6
28.3
110
52.2
23.6
34.9
102
15.7
35.6
92.4
32
21.9
97.2
37.5
60.2
Basha
Rajan
Elumalai
Mani
Jothi
Subramani
Premkumar
Prabu
Dhinakaran
Ragavan
Kathirvel
Kuppaiah
15
18
16
7
11
17
16
10
20
15
15
13
9
17
30
11
